Abstract
Thrombocytopenia is one of the most common hematological abnormalities found in neonates. The causes, treatment modalities, and outcomes of neonatal thrombocytopenia have to be evaluated for providing better care and follow-up. In this study, our aim was to assess the prevalence, causes, treatment modalities, and outcomes of thrombocytopenia in neonates. A retrospective analysis was conducted on the medical records of all neonates hospitalized at our hospital between January 2007 and December 2011 and those with thrombocytopenia were included in the study. Of the 3,515 neonates, 134 (3.8 %) had thrombocytopenia. Ninety-seven of them (72 %) were preterm. In the patients admitted to neonatal intensive care unit, the prevalence of thrombocytopenia was found as 12 %, whereas it was found as 1.2 % in neonatal service. The highest prevalence was detected in the year 2008 by 5.3 %, and the lowest prevalence was detected in the year 2011 by 2.4 %. Sepsis was the most common etiologic factor between years 2007 and 2009. Intrauterine growth restriction, metabolic disorders, drugs, and asphyxia were more common causes in the recent years. Severe thrombocytopenia was found in 26 % of neonates and 11 % of thrombocytopenic neonates had major hemorrhage. Intracranial hemorrhage ratio was 5.9 % and all of these patients were preterm. Thrombocytopenia improved in 92.5 % of patients and persisted in 3 % of patients. Death occurred in 4.5 % of neonates. This study shows that the causes of neonatal thrombocytopenia may show variations with respect to time and the prevalence, complications, and risks of thrombocytopenia may be lowered by eliminating preventable factors.
Similar content being viewed by others
References
Roberts I, Stanworth S, Murray NA (2008) Thrombocytopenia in the neonate. Blood Rev 22:173–186
Sola-Vishner M, Saxonhouse MA, Brown RE (2008) Neonatal thrombocytopenia: what we do and don't know. Early Hum Dev 84:499–506
Roberts I, Murray NA (2003) Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 88:359–364
Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G, Immune Thrombocytopenia Working Group (1997) Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 89:4402–4406
Stanworth SJ, Clarke P, Watts T, Ballard S, Choo L, Morris T, Murphy MF, Roberts I (2009) Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 124:826–834
Oren H, İrken G, Oren B, Olgun N, Ozkan H (1994) Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia. Indian J Pediatr 61:551–558
Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C (1986) Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 108:749–755
Mehta P, Rohitkumar V, Neumann L et al (1980) Thrombocytopenia in the high risk infant. J Pediatr 97:791–794
Christensen RD, Henry E, Wiedmeier S, Karpatkin M (2006) Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 26:348–353
Murray NA, Roberts IA (1996) Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 40:112–119
Watts TL, Roberts IAG (1999) Hematological abnormalities in the growth-restricted infant. Semin Neonatol 4:41–54
Murray NA, Howarth LJ, McCloy MP, Letsky EA, Roberts IA (2002) Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 12:35–41
Sola MC, Rimsza LM (2002) Mechanisms underlying thrombocytopenia in the neonatal intensive care unit. Acta Pediatrica Suppl 12:35–41
Sallmon H, Sola-Visner M (2012) Clinical and research issues in neonatal anemia and thrombocytopenia. Curr Opin Pediatr 24:16–22
von Lindern JS, van den Bruele T, Lopriore E, Walther FJ (2011) Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr 11:16–22
Gommella TL (2004) Neonatology: management, procedures, on-call problems, diseases, and drugs, 5th edn. McGraw-Hill, New York
Kent AL, Wright IM, Abdel-Latif ME (2012) Mortality and adverse neurologic outcomes are greater in preterm male infants. Pediatrics 129:124–131
Bhat YR, Cherian CS (2008) Neonatal thrombocytopenia associated with maternal pregnancy induced hypertension. Indian J Pediatr 75:571–573
Roberts I, Murray NA (2008) Neonatal thrombocytopenia. Semin Fetal Neonatal Med 13:256–264
Beachy J (2011) Neonatal alloimmune thrombocytopenia: a case study. Neonatal Net 30:402–407
Uhrynowska M, Niznikowska-Marks M, Zupańska B (2000) Neonatal and maternal thrombocytopenia: incidence and immune background. Eur J Haematol 64:42–46
Chakravorty S, Murray N, Roberts I (2005) Neonatal thrombocytopenia. Early Hum Dev 81:35–41
Chakravorty S, Roberts I (2012) How I manage neonatal thrombocytopenia. Br J Haematol 156:155–162
Holzhauer S, Zieger B (2011) Diagnosis and management of neonatal thrombocytopenia. Semin Fetal Neonatal Med 16:305–310
Christensen RD (2011) Platelet transfusion in the neonatal intensive care unit: benefits, risks, alternatives. Neonatology 100:311–318
Sola-Visner M, Sallmon H, Brown R (2009) New insights into the mechanisms of nonimmune thrombocytopenia in neonates. Semin Perinatol 33:43–51
Alexander F, Chiu L, Kroh M, Hammel J, Moore J (2009) Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus. J Pediatr Surg 44:112–117
Linder N, Bello R, Hernandez A, Rosen C, Birk E, Sirota L, Pushkov Y, Klinger G (2010) Treatment of patent ductus arteriosus: indomethacin or ibuprofen? Am J Perinatol 27:399–404
Little DC, Pratt TC, Blalock SE, Krauss DR, Cooney DR, Custer MD (2003) Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 38:492–496
Jain S (1994) Ibuprofen-induced thrombocytopenia. Br J Clin Pract 48:51–52
Murray N, Ballard S, Casbard A (2006) A multi-centre prospective observational study of platelet transfusion practice in neonates with severe thrombocytopenia. Blood 108:287
Baer VL, Lambert DK, Henry E, Snow GL, Sola-Visner MC, Christensen RD (2007) Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system. J Perinatol 27:790–796
Garcia MG, Duenas E, Sola MC, Hutson AD, Theriaque D, Christensen RD (2001) Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 21:415–420
Del Vecchio A, Sola MC, Theriaque DW, Hutson AD, Kao KJ, Wright D, Garcia MG, Pollock BH, Christensen RD (2001) Platelet transfusions in the neonatal intensive care unit: factors predicting which patients will require multiple transfusions. Transfusion 41:803–808
Christensen RD, Henry E, Del Vecchio A (2012) Thrombocytosis and thrombocytopenia in the NICU: incidence, mechanisms and treatments. J Matern Fetal Neonatal Med 25:15–17
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ulusoy, E., Tüfekçi, Ö., Duman, N. et al. Thrombocytopenia in neonates: causes and outcomes. Ann Hematol 92, 961–967 (2013). https://doi.org/10.1007/s00277-013-1726-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-013-1726-0